Human thyroid carcinoma cell invasion is controlled by the low density lipoprotein receptor-related protein-mediated clearance of urokinase plasminogen activator

International Journal of Biochemistry and Cell Biology

Volumn 38, Issue 10, 2006, Pages 1729-1740

  Sid, Brice ^a   Dedieu, Stephane ^a   Delorme, Nathalie ^a   Sartelet, Herve ^a   Rath, Geraldine M ^a   Bellon, Georges ^a   Martiny, Laurent ^a  

^a CNRS   (France)

Author keywords

Low density lipoprotein receptor related protein; Thyroid carcinoma; Tumor invasion; Urokinase

Indexed keywords

GELATINASE A; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PROTEIN ANTIBODY; PROTEIN INHIBITOR; SCAVENGER RECEPTOR; UROKINASE;

ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL INVASION; CELL SURFACE; FOLLICULAR CARCINOMA; HUMAN; HUMAN CELL; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; THYROID CARCINOMA; THYROID CELL;

ANTIBODIES; CARCINOMA; CELL LINE, TUMOR; CELL MEMBRANE; HUMANS; LDL-RECEPTOR RELATED PROTEIN 1; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; THYROID NEOPLASMS; URINARY PLASMINOGEN ACTIVATOR;

EID: 33745428139     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2006.04.005     Document Type: Article

References (52)

1. Agren M.S., Mirastschijski U., Karlsmark T., and Saarialho-Kere U.K. Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds. Experimental Dermatology 10 (2001) 337-348
2. Barmina O.Y., Walling H.W., Fiacco G.J., Freije J.M., Lopez-Otin C., Jeffrey J.J., et al. Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization. The Journal of Biological Chemistry 274 (1999) 30087-30093
3. Baum L., Dong Z.Y., Choy K.W., Pang C.P., and Ng H.K. Low density lipoprotein receptor related protein gene amplification and 766T polymorphism in astrocytomas. Neuroscience Letters 256 (1998) 5-8
4. Bein K., and Simons M. Thrombospondin type 1 repeats interact with matrix metalloproteinase. 2. Regulation of metalloproteinase activity. The Journal of Biological Chemistry 275 (2000) 32167-32173
5. Bu G., Maksymovitch E.A., Geuze H., and Schwartz A.L. Subcellular localization and endocytic function of low density lipoprotein receptor-related protein in human glioblastoma cells. The Journal of Biological Chemistry 269 (1994) 29874-29882
6. Chapman H.A., and Wei Y. Protease crosstalk with integrins: the urokinase receptor paradigm. Thrombosis and Haemostasis 86 (2001) 124-129
7. Chazaud B., Ricoux R., Christov C., Plonquet A., Gherardi R.K., and Barlovatz-Meimon G. Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations. American Journal of Pathology 160 (2002) 237-246
8. Czekay R.P., Kuemmel T.A., Orlando R.A., and Farquhar M.G. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity. Molecular Biology of the Cell 12 (2001) 1467-1479
9. Degryse B., Neels J.G., Czekay R.P., Aertgeerts K., Kamikubo Y., and Loskutoff D.J. The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1. The Journal of Biological Chemistry 279 (2004) 22595-22604
10. Degryse B., Resnati M., Rabbani S.A., Villa A., Fazioli F., and Blasi F. Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. Blood 94 (1999) 649-662
11. Degryse B., Sier C.F., Resnati M., Conese M., and Blasi F. PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor. FEBS Letters 505 (2001) 249-254
12. Emonard H., Bellon G., Troeberg L., Berton A., Robinet A., Henriet P., et al. Low density lipoprotein receptor-related protein mediates endocytic clearance of pro-MMP-2. TIMP-2 complex through a thrombospondin-independent mechanism. The Journal of Biological Chemistry 279 (2004) 54944-54951
13. Frederiks W.M., and Mook O.R. Metabolic mapping of proteinase activity with emphasis on in situ zymography of gelatinases: review and protocols. Journal oh Histochemistry and Cytochemistry 52 (2004) 711-722
14. Goretzki P.E., Frilling A., Simon D., and Roeher H.D. Growth regulation of normal thyroids and thyroid tumors in man. Recent Results in Cancer Research 118 (1990) 48-63
15. Granelli-piperno A., and Reich E. A study of proteases and protease inhibitor complexes in biological fluids. The Journal of Experimental Medicine 148 (1978) 223-224
16. Hahn-Dantona E., Ruiz J.F., Bornstein P., and Strickland D.K. The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism. The Journal of Biological Chemistry 276 (2001) 15498-15503
17. Hao J.L., Nagano T., Nakamura M., Kumagai N., Mishima H., and Nashida T. Effect of galardin on collagen degradation by Pseudomonas aeruginosa. Experimental Eye Research 69 (1999) 595-601
18. Herz J., Goldstein J.L., Strickland D.K., Ho Y.K., and Brown M.S. 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. The Journal of Biological Chemistry 266 (1991) 21232-21238
19. Herz J., and Strickland D.K. LRP: a multifunctional scavenger and signaling receptor. The Journal of Clinical Investigation 108 (2001) 779-784
20. Hornebeck W., Emonard H., Monboisse J.C., and Bellon G. Matrix-directed regulation of pericellular proteolysis and tumor progression. Seminars in Cancer Biology 12 (2002) 231-241
21. Kancha R.K., Stearns M.E., and Hussain M.M. Decreased expression of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in invasive cell clones derived from human prostate and breast tumor cells. Oncology Research 6 (1994) 365-372
22. Kauhanen P., Siren V., Carpen O., Vaheri A., Lepantalo M., and Lassila R. Plasminogen activator inhibitor-1 in neointima of vein grafts: its role in reduced fibrinolytic potential and graft failure. Circulation 96 (1997) 1783-1789
23. Keski-Oja J., Lohi J., Tuuttila A., Tryggvason K., and Vartio T. Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator. Experimental Cell Research 202 (1992) 471-476
24. Kounnas M.Z., Argraves W.S., and Strickland D.K. The 39-kDa receptor-associated protein interacts with two members of the low density lipoprotein receptor family, alpha 2-macroglobulin receptor and glycoprotein 330. The Journal of Biological Chemistry 267 (1992) 21162-21166
25. Lakkaraju A., Rahman Y.E., and Dubinsky J.M. Low-density lipoprotein receptor-related protein mediates the endocytosis of anionic liposomes in neurons. The Journal of Biological Chemistry 277 (2002) 15085-15092
26. Li Y., Knisely J.M., Lu W., McCormick L.M., Wang J., Henkin J., et al. Low density lipoprotein (LDL) receptor-related protein 1B impairs urokinase receptor regeneration on the cell surface and inhibits cell migration. The Journal of Biological Chemistry 277 (2002) 42366-42371
27. Li Y., Lu W., and Bu G. Essential role of the low density lipoprotein receptor-related protein in vascular smooth muscle cell migration. FEBS Letters 555 (2003) 346-350
28. Li Y., Wood N., Grimsley P., Yellowlees D., and Donnelly P.K. In vitro invasiveness of human breast cancer cells is promoted by low density lipoprotein receptor-related protein. Invasion Metastasis 18 (1998-1999) 240-251
29. Medh J.D., Fry G.L., Bowen S.L., Pladet M.W., Strickland D.K., and Chappell D.A. The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors. The Journal of Biological Chemistry 270 (1995) 536-540
30. Nykjaer A., Conese M., Christensen E.I., Olson D., Cremona O., and Gliemann J. Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. The EMBO Journal 16 (1997) 2610-2620
31. Nykjaer A., Petersen C.M., Moller B., Jensen P.H., Moestrup S.K., Holtet T.L., et al. Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. The Journal of Biological Chemistry 267 (1992) 14543-14546
32. Okada S.S., Grobmyer S.R., and Barnathan E.S. Contrasting effects of plasminogen activators, urokinase receptor and LDL receptor-related protein on smooth muscle cells migration and invasion. Arteriosclerosis, Thrombosis, and Vascular Biology 16 (1996) 1269-1276
33. Orr A.W., Elzie C.A., Kucik D.F., and Murphy-Ullrich J.E. Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration. Journal of Cell Science 116 (2003) 2917-2927
34. Quax P.H., de Bart A.C., Schalken J.A., and Verheijen J.H. Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: correlation with metastatic behavior in vivo. Prostate 32 (1997) 196-204
35. Saksela O., Wahström T., Lehtovirta P., Seppälä M., and Vaheri A. Presence of α2-macroglobulin in normal but not in malignant syncytiotrophoblasts. Cancer Research 41 (1981) 2507-2513
36. Sidenius N., and Blasi F. The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Review 22 (2003) 205-222
37. Smit J.W., van der Pluijm G., Romijn H.A., Lowik C.W., Morreau H., and Goslings B.M. Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation system. Thyroid 9 (1999) 913-919
38. Soula-Rothhut M., Coissard C., Sartelet H., Boudot C., Bellon G., Martiny L., et al. The tumor suppressor PTEN inhibits EGF-induced TSP-1 and TIMP-1 expression in FTC-133 thyroid carcinoma cells. Experimental Cell Research 304 (2005) 187-201
39. Stahl A., and Mueller B.M. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Research 54 (1994) 3066-3071
40. Strickland D.K., Ashcom J.D., Williams S., Burgess W.H., Migliorini M., and Argraves W.S. Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. The Journal of Biological Chemistry 265 (1990) 17401-17404
41. Strickland D.K., and Ranganathan S. Diverse role of LDL receptor-related protein in the clearance of proteases and in signaling. Journal of Thrombosis and Haemostasis 1 (2003) 1663-1670
42. Van Leuven F., Cassiman J.J., and Van den Berghe H. Demonstration of an α2-macroglobulin receptor in human fibroblasts, absent in tumor-derived cell lines. The Journal of Biological Chemistry 254 (1979) 5155-5160
43. Vihinen P., Ala-aho R., and Kahari V.M. Matrix metalloproteinases as therapeutic targets in cancer. Current Cancer Drug Targets 5 (2005) 203-220
44. Weaver A.M., Hussaini I.M., Mazar A., Henkin J., and Gonias S.L. Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin. The Journal of Biological Chemistry 272 (1997) 14372-14379
45. Webb D.J., Nguyen D.H.D., and Gonias S.L. Extracellular signal-regulated kinase functions in the urokinase receptor dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion. Journal of Cell Science 113 (2000) 123-134
46. Webb D.J., Nguyen D.H., Sankovic M., and Gonias S.L. The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro. The Journal of Biological Chemistry 274 (1999) 7412-7420
47. Wijnberg M.J., Quax P.H., Nieuwenbroek N.M., and Verheijen J.H. The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by alpha2-macroglobulin receptor associated protein. Thrombosis and Haemostasis 78 (1997) 880-886
48. Williams S.E., Ashcom J.D., Argraves W.S., and Strickland D.K. A novel mechanism for controlling the activity of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Multiple regulatory sites for 39-kDa receptor-associated protein. The Journal of Biological Chemistry 267 (1992) 9035-9040
49. Yamamoto M., Ikeda K., Oshshima K., Tsugo H., Kimura H., and Tomonaga M. Increased expression of low density lipoprotein receptor-related protein/α2-macroglobulin receptor in human malignant astrocytomas. Cancer Research 57 (1997) 2799-2805
50. Yang Z., Eton D., Zheng F., Livingstone A.S., and Yu H. Effect of tissue plasminogen activator on vascular smooth muscle cells. Journal of Vascular Surgery 42 (2005) 532-538
51. Yang Z., Strickland D.K., and Bornstein P. Extracellular matrix metalloproteinase 2 levels are regulated by the low density lipoprotein-related scavenger receptor and thrombospondin 2. The Journal of Biological Chemistry 276 (2001) 8403-8408
52. Zhang J.C., Sakthivel R., Kniss D., Graham C.H., Strickland D.K., and McCrae K.R. The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor regulates cell surface plasminogen activator activity on human trophoblast cells. The Journal of Biological Chemistry 273 (1998) 32273-32280